(CRWE, GALE, OMER, GTXI) Stocks under Consideration by CRWEFinance.com

Crown Equity Holdings Inc. (CRWE) Most business managers’ initial reaction to VoIP is surprise at the incredibly low prices their packages are offered at in comparison to those offered by traditional services. Since many of their customers are switching to the more efficient systems, most traditional telephone services are becoming more expensive, while the services everyone is switching to cost only a fraction of those old prices. Some people might think that a lower cost will equate to a lower quality service with less features, but the truth of the matter is that VoIP packages are known for high quality and more features than any traditional service is capable of offering. Crown Equity Holdings Inc. (CRWE.OB) (www.crownequityholdings.com) recently reported that its subsidiary Crown Tele Services Inc. has entered into a letter of intent with BBN Solutions. BBN Solutions, located in India, and Crown Tele Services Inc. (www.crownteleservices.com) shall form a 50/50 Joint Venture corporation for the purpose of granting to Crown Tele Services Inc., exclusive rights in the United States to BBN’s telecommunications marketing process and services. BBN Solutions doing business as BBN Telecom provides both wholesale and retail global communication, as well as calling cards. For more information visit www.bbntel.net. Commenting on the Letter of Intent, Kenneth Bosket, President of Crown Tele Services Inc., stated: “This Joint Venture will give both companies a strategic advantage within the communication market. Crown Tele Services Inc. is a provider of affordable, world class (VoIP) communications solutions and is a subsidiary of Crown Equity Holdings Inc. For more information visit www.crownteleservices.com Crown Equity Holdings Inc. offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. Its advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. For more information visit www.crownequityholdings.com. For more information, please visit their website: http://www.crownequityholdings.com ********************************************* Galena Biopharma, Inc. (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, announced the appointment of David A. Scheinberg, M.D., Ph.D. to the Company’s Scientific Advisory Board (SAB). Galena Biopharma, Inc., a biotechnology company, engages in discovering, developing, and commercializing innovative therapies addressing unmet medical needs using targeted bio therapeutics. ********************************************* Omeros Corporation (NASDAQ:OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, is scheduled to present at the Cowen and Company 32nd Annual Health Care Conference taking place in Boston, Massachusetts next week. The presentation is scheduled for Wednesday, March 7, 2012 at 11:20 a.m. Eastern Time. The presentation will be webcast. The live and archived webcasts can be accessed on the “Events” page of the Company’s website at www.omeros.com. Omeros Corporation, a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing products targeting inflammation, coagulopathies, and disorders of the central nervous system. ********************************************* GTx, Inc. (Nasdaq:GTXI) announced that management will present a company overview on March 7, 2012 at the Cowen and Co. Annual Health Care Conference in Boston. The GTx presentation will begin at 11:20 a.m. Eastern Time. A simultaneous webcast of the presentation will be accessible from the GTx website at www.gtxinc.com. An archived replay of the presentation will be available on the company website until March 21. GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. ******************************************************************** Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.